Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon pathway activation in systemic lupus erythematosus.

Mary K Crow1

  • 1Hospital for Special Surgery, New York, NY 10021, USA. crowm@hss.edu

Current Rheumatology Reports
|November 24, 2005
PubMed
Summary

Interferon (IFN) pathways are key to understanding systemic lupus erythematosus (SLE) and offer therapeutic targets. Measuring IFN-inducible genes and IFN-alpha aids in identifying active SLE patients for targeted treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An NT5E loss-of-function variant permits tissue inflammation and hypertension in systemic lupus erythematosus.

iScience·2026
Same author

Whole blood transcriptome profiling in patients treated with deucravacitinib and novel mechanistic insights into TYK2 inhibition in lupus: results from a post hoc analysis of the PAISLEY SLE phase 2 trial.

Annals of the rheumatic diseases·2026
Same author

Chasing the target: reports from the Advances in Targeted Therapies meeting, 2025.

Annals of the rheumatic diseases·2026
Same author

Type I interferons in health and disease: molecular aspects and clinical implications.

Physiological reviews·2025
Same author

Chasing the target: reports from the Advances in Targeted Therapies meeting, 2024.

Annals of the rheumatic diseases·2025
Same author

Mechanosensing regulates pDC activation in the skin through NRF2 activation.

The Journal of experimental medicine·2024

Area of Science:

  • Immunology
  • Rheumatology
  • Genetics

Background:

  • Systemic lupus erythematosus (SLE) involves complex immune dysregulation.
  • A multitude of interferon (IFN)-inducible genes are coordinately expressed in SLE patients' peripheral blood cells.
  • Decades of research implicate IFN-alpha in the pathogenesis of SLE.

Purpose of the Study:

  • To highlight the significance of the IFN pathway as a therapeutic target in lupus.
  • To emphasize the role of IFN-alpha in SLE mechanisms.
  • To discuss the utility of IFN-inducible gene assays and IFN-alpha quantification in SLE management.

Main Methods:

  • Analysis of gene expression patterns in peripheral blood cells of SLE patients.
  • Quantification of IFN-alpha protein levels in plasma.
  • Investigation into the mechanisms driving IFN pathway activation.

Main Results:

  • Coordinated expression of IFN-inducible genes is a hallmark of SLE.
  • IFN-alpha is strongly implicated in SLE pathogenesis.
  • Assays for IFN-inducible genes and IFN-alpha provide tools for disease assessment.

Conclusions:

  • The IFN pathway is a central focus for understanding autoimmunity and inflammation in SLE.
  • Current assays can identify SLE patients likely to respond to therapies targeting the innate immune system.
  • Understanding IFN pathway activation mechanisms may reveal triggers of SLE autoimmunity.

Related Experiment Videos